Yuetiva Deming, Ph.D.
Affiliations: | 2011-2018 | Department of Psychiatry | Washington University School of Medicine, St. Louis, MO, United States |
2018- | Department of Medicine | University of Wisconsin, Madison, Madison, WI |
Area:
Genetics, NeuroscienceGoogle:
"Yuetiva Deming"Mean distance: (not calculated yet)
Parents
Sign in to add mentorKrista M. Rodgers | research assistant | 2009-2011 | CU Boulder | |
(I was an undergraduate research assistant) | ||||
Carlos Cruchaga | grad student | 2011-2017 | Washington University School of Medicine | |
Barbara B. Bendlin | post-doc | 2018- | UW Madison | |
Corinne D. Engelman | post-doc | 2018- | UW Madison (Epi Tree) | |
Carlos Cruchaga | post-doc | 2017-2018 | Washington University School of Medicine in St. Louis |
Collaborators
Sign in to add collaboratorLogan C. Dumitrescu | collaborator | 2017- | Vanderbilt (Computational Biology Tree) |
Michael Ewers | collaborator | 2017- | Ludwig Maximilian University Munich |
Christian Haass | collaborator | 2017- | Ludwig Maximilian University Munich |
Timothy J. Hohman | collaborator | 2017- | Vanderbilt |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rubinski A, Dewenter A, Zheng L, et al. (2023) Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner. European Journal of Nuclear Medicine and Molecular Imaging |
Heston MB, Hanslik KL, Zarbock KR, et al. (2023) Gut inflammation associated with age and Alzheimer's disease pathology: a human cohort study. Scientific Reports. 13: 18924 |
Xu Y, Sun Z, Jonaitis E, et al. (2023) Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Dong R, Lu Q, Kang H, et al. (2023) CSF metabolites associated with biomarkers of Alzheimer's disease pathology. Frontiers in Aging Neuroscience. 15: 1214932 |
Xu Y, Vasiljevic E, Deming YK, et al. (2023) Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. Journal of Alzheimer's Disease : Jad |
Xu Y, Sun Z, Jonaitis E, et al. (2023) Apolipoprotein E moderates the association between Non- Polygenic Risk Score for Alzheimer's Disease and Aging on Preclinical Cognitive Function. Medrxiv : the Preprint Server For Health Sciences |
Wang C, Western D, Yang C, et al. (2023) Unique genetic architecture of CSF and brain metabolites pinpoints the novel targets for the traits of human wellness. Research Square |
Panyard DJ, McKetney J, Deming YK, et al. (2023) Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Deming Y, Vasiljevic E, Morrow A, et al. (2023) Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Xu Y, Vasiljevic E, Deming YK, et al. (2023) Effect of Pathway-specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals. Medrxiv : the Preprint Server For Health Sciences |